Content Type: Article

  • The Suspension of Dividend Distributions and Share Buyback Programs for Stabilisation in Times of Crisis

    The Suspension of Dividend Distributions and Share Buyback Programs for Stabilisation in Times of Crisis

    ARTICLE

    The Suspension of Dividend Distributions and Share Buyback Programs for Stabilisation in Times of Crisis

    April 8, 2020

    Read time: 2 min

    Key takeaways
    Overview

    In this article, authors Andrea Stockhorst, Renate Prinz and Frederic Peine provide an overview of the current regulatory assessment of dividend payments and share buybacks by credit institutions, in particular against the background of government aid programs and the flexibililty of regulatory requirements with regard to capital and liquidity presented by the banking supervision in connection with the COVID-19 pandemic in Germany. Following an assessment under stock corporation law of the suspension of dividend payments to shareholders, the authors to discuss the basic principles of the permissibly of share buyback programs, in particular authorising the management board through the annual general meeting, and implications under capital market law. The article concludes with an outlook on considerations and scope for action that should be taken into account when granting dividends and conducting share buybacks.

    In depth
    Authors
    More insights

  • CARES Act Social Security Tax Deferral and Employee Retention Credits

    CARES Act Social Security Tax Deferral and Employee Retention Credits

    ARTICLE / CLIENT ALERT

    CARES Act Social Security Tax Deferral and Employee Retention Credits

    April 7, 2020

    Read time: 6 min

    Key takeaways
    Overview

    The CARES Act provides for payroll tax relief, including employee retention tax credits and the deferral of all employer Social Security tax payments to help employers in the face of economic hardship related to the COVID-19 pandemic. Employers should work with their tax advisors, payroll providers, and payroll departments to immediately implement these valuable savings.

    In depth

    The broad-based employer and employee relief provided under the Coronavirus Aid, Relief, and Economic Security (CARES) Act includes two forms of payroll tax relief related to an employer’s Social Security tax payments: deferral of all employer Social Security tax payments, and employee retention tax credits of up to $5,000 for qualified wages paid to employees. All employers should consider taking advantage of these valuable tax savings to alleviate the broad and deep impact of the Coronavirus (COVID-19) pandemic on businesses and their employees.

    Employer Social Security tax deferrals

    Employers pay Social Security taxes at a rate of 6.2% on the first $137,700 of wages paid to employees for calendar year 2020. The CARES Act allows all employers to defer payment of employer Social Security taxes that are otherwise owed for wage payments made after March 27, 2020, through the end of the calendar year. Instead of depositing these taxes on a next-day or semi-weekly basis, the deposit due date for 50% of the taxes is deferred to December 31, 2021, with the remaining 50% deferred until December 31, 2022.

    All employers should work with their payroll provider, payroll departments or payroll software to immediately begin deferring these employer Social Security taxes. The only possible exception is employers that are applying for the Small Business Administration (SBA) loans under the CARES Act. Even these employers are eligible for the deferrals until they receive loan forgiveness.

    Employee retention payroll tax credits

    What are the employee retention credits?

    The employee retention credits are quarterly refundable payroll tax credits intended to incentivize employers to retain employees on their payrolls amid the economic hardships related to the pandemic. They are refundable credits against an employer’s Social Security tax obligations with a maximum annual credit of $5,000 on the “qualified wages” paid to each employee. Although the employee retention credits are quite broad, important limitations exist. The most notable are highlighted below.

    What conditions make an employer eligible for employee retention credits?

    An employer’s initial eligibility is triggered if either of two COVID-19 economic hardships arise within a calendar quarter for 2020:

    1. The employer’s operations are partially or fully suspended due to a governmental order limiting commerce, travel or group meetings.
    2.  The employer experiences a significant decline in gross receipts.

    Although this analysis is based on facts and circumstances, no guidance has been issued regarding what constitutes a partial or full suspension of business due to a governmental order. The more objective “significant decline” in gross receipts occurs during a calendar quarter where gross receipts are less than 50% of gross receipts for the same calendar quarter in 2019. Once the initial credit is triggered under the gross receipts test, the credits remain available throughout the calendar year unless the employer’s gross receipts for a subsequent 2020 calendar quarter exceed 80% of those for the corresponding calendar quarter in 2019.

    Employers receiving an SBA loan under the CARES Act’s Paycheck Protection Program are not eligible for employee retention credits. In addition, the employee retention credits can be offset by payroll tax credits taken by employers under the Families First Coronavirus Response Act in connection with mandated leave.

    What is the value of the employee retention credits?

    The employee retention credits equal 50% of the “qualified wages” that an eligible employer pays in a calendar quarter, subject to a $10,000 cap (so that the maximum credit for wages paid to any employee is $5,000). Wages paid between March 13, 2020, and December 31, 2020, are eligible for credit.

    What constitutes “qualified wages” for the employee retention credits?

    The answer depends on the average size of the employer’s full-time employee workforce (i.e., employees working 30 or more hours per week) in 2019, with more stringent criteria for larger businesses:

    • More than 100 full-time employees: qualified wages are all wages paid to an employee for the time that the employee is “not providing services” due to the COVID-19 economic hardship period.
    • 100 or fewer full-time employees: qualified wages are the wages paid to any employee during the COVID-19 economic hardship period.

    What are “wages” for purposes of the employee retention credits?

    The basic wage calculation focuses on Social Security wages as reflected in Box 3 of the Form W-2 that are paid from March 13, 2020, through December 31, 2020, except that these may be increased by the employer’s healthcare expenses allocated to each employee, e.g., nontaxable premiums and/or COBRA coverage. Wages paid for which a credit was claimed under the Families First Act must be excluded from this Box 3 calculation. However, any additional wages paid to the employee may be counted as wages for purposes of the CARES Act employee retention credits.

    How do employers claim the employee retention credits?

    As refundable payroll tax credits, the credits can be obtained using procedures and methods modeled after the recoupment methods for any other overpaid federal payroll taxes during the calendar quarter. In other words, even though the employee retention tax credit is an employer Social Security tax credit, the employer can recoup the credit by reducing the tax deposits that would otherwise be made for employee federal income tax withholding, the employee Social Security/Medicare taxes and the employer Social Security/Medicare taxes. If those amounts are insufficient to recoup the taxes, the employer can request an advance from the Internal Revenue Service by completing and submitting a Form 7200 (Advance Payment of Employer Credits Due to COVID-19).

    Authors
    More insights

  • COVID-19 – The Regulatory Effects on the Real Estate Industry in Germany

    ARTICLE / CLIENT ALERT

    COVID-19 – The Regulatory Effects on the Real Estate Industry in Germany

    April 6, 2020

    Read time: 2 min

    Key takeaways
    Overview

    The Coronavirus epidemic doesn’t spare the real estate industry. This can especially be witnessed due to the numerous missed rent payments which constitute a challenge for real estate investors. The legal consequences of the current situation with regard to rent have already been discussed in depth. However, real estate fund managers and their asset managers are also facing regulatory issues: How can real estate funds currently be evaluated? Are contractual or statutory exceptions an option? Is this a situation which requires exceptional evaluations of properties? And which degree of (regulatory) discretion do fund managers and their asset managers enjoy during negotiations with tenants concerning a deferral of rent payments and/or the use of rent securities?

    Read the full article in German here.

    In depth
    Authors

    Frank Müller

    Partner

    Frankfurt

    More insights

  • PIPEs and Registered Directs: COVID-19 and Alternative Financing Transactions

    PIPEs and Registered Directs: COVID-19 and Alternative Financing Transactions

    ARTICLE / CLIENT ALERT

    PIPEs and Registered Directs: COVID-19 and Alternative Financing Transactions

    April 7, 2020

    Read time: 6 min

    Key takeaways
    Overview
    • A Source of Capital and Investment Opportunity in Stressed Markets
    • Speed of Capital
    • Few Execution Hurdles
    • Advantageous Deal Terms

    Among the myriad issues raised by the COVID-19 pandemic is the need for alternative sources of financing for public companies. Private Investment in Public Equity (“PIPE”) and related transaction structures are a prime way to provide this capital. Hedge and other investment funds are adept in PIPEs and are well positioned to invest.

    These transactions can be done quickly, even overnight. In a PIPE transaction, investors purchase equity or equity linked securities, such as common stock, convertible preferred stock, convertible notes and warrants, directly from the issuer. The securities can be sold pursuant to an exemption from registration under the Securities Act of 1933 (a PIPE) or off a shelf registration statement (commonly referred to as a “Registered Direct” transaction).

    PIPEs. PIPEs issue restricted securities requiring a subsequent resale registration statement, exemption or holding period to be resold. PIPE investors typically receive a discount to compensate for the illiquidity, although many PIPEs are actually priced at a premium to market. Attractively, an issuer facing public reporting issues, perhaps due to the impact of COVID-19 on their financial reporting, can still conduct a PIPE issuance because of the private nature of the transaction.

    Registered Direct Transactions. In Registered Direct transactions, securities are issued off an effective shelf registration statement. These securities can be resold by investors immediately without any subsequent registration, commonly leading to tighter pricing. Issuers with an existing, effective shelf registration statement have already gone through the SEC comment process prior to effectiveness and can issue the securities instantaneously. Well-known seasoned issuers, or WKSIs, can file new registration statements which are effective immediately so they can conduct this type of offering also on the spot. Any issuer looking to conduct a Registered Direct offering will need to be current in its SEC reporting obligations.

    Structuring Issues. Investors should keep these key issues in mind when structuring or analyzing these types of deals:

    • Capital Structure. Consider where you want to be in the capital structure (common equity, preferred equity or debt — senior and/or secured) and whether that will be achievable under the issuer’s existing debt documents and/or the terms of existing senior securities.
    • Protective Provisions. Consider board seats or other control rights in order to get comfortable with the risk profile. In structured deals, consider protective provisions such as collateral, event of default redemptions, restrictive covenants and put rights.
    • Exchange Rules. Issuers listed on the NYSE or Nasdaq have to comply with the listing rules of the applicable exchange.
    • Deal Size. Both Nasdaq and the NYSE rules generally require that issuers obtain shareholder approval prior to certain issuances of 20% or more of their stock as well as issuances which result in a “change of control” under the exchange rules. In addition, NYSE rules can limit the amount an issuer can issue to a “substantial security holder.” These rules can be complex, but can, in most cases, be dealt with through careful structuring and effective April 6, 2020 until June 30, 2020, the NYSE shareholder approval requirements for issuances of 20% or more and issuances to “substantial security holders” have been partially waived in response to the market and general economic disruption caused by COVID-19. Also, an issuer may be able to rely on a “financial hardship exemption” to the shareholder approval requirements if a delay in obtaining shareholder approval would “seriously jeopardize the financial viability” of the issuer. Some issuers may meet this standard due to the impact of the COVID-19 outbreak.
    • Board Seats. Investors seeking board appointment rights should be aware that these rights may need to comply with the proportionate voting rules of the stock exchanges.
    • SEC Beneficial Ownership Rules. Investors should be cognizant of the SEC’s beneficial ownership reporting requirements and other implications under Section 13 and Section 16 of the Securities Exchange Act of 1934. These rules apply to greater than 5% and 10% beneficial owners, respectively. Investors looking to stay below these thresholds may be able to do so by structuring appropriately.
    • Registration, Resale and Liquidity. Investors in PIPE transactions can negotiate to have their shares registered after the deal is completed. Once that registration is effective and current, the PIPE securities can be freely sold into the market. Some investors choose to forego registration and rely on exemptions from registration, such as Rule 144, to resell their securities. Rule 144 requires a minimum six-month holding period and requires that the issuer is current in its public filings until a 12-month holding period is completed (or indefinitely if the issuer was ever a shell company or for affiliates of the issuer). An issuer’s ability to file a registration statement and/or remain current in its public filings will impact an investor’s liquidity and it may be necessary to include deal terms to account for this risk, such as liquidated damages, events of default, put rights and collateral.

    Investors well positioned to participate in these types of alternative financing transactions will undoubtedly find attractive investment opportunities in today’s unprecedented environment.

    Authored by Eleazer Klein, Adriana Schwartz and Clara Zylberg.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    This is a fast-moving topic and the information contained in this Alert is current as of the date it was published.

    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2020 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Ele Klein

    Partner

    New York – 919 Third Avenue

    More insights

  • Flexibilities for Rural Health Centers, Federally Qualified Health Centers During COVID-19

    Flexibilities for Rural Health Centers, Federally Qualified Health Centers During COVID-19

    ARTICLE / CLIENT ALERT

    Flexibilities for Rural Health Centers, Federally Qualified Health Centers During COVID-19

    April 6, 2020

    Read time: 7 min

    Key takeaways
    Overview

    This alert was updated on April 13, 2020.

    The Centers for Medicare and Medicaid Services released a fact sheet detailing flexibilities for Rural Health Clinics and Federally Qualified Health Centers during the Coronavirus (COVID-19) pandemic. During the national emergency period, both entity types may serve as distant site telehealth providers for Medicare, and may provide visiting nursing services at a Medicare patient’s home with fewer requirements.

    In depth

    The Centers for Medicare and Medicaid Services (CMS) recently released guidance to Rural Health Clinics (RHCs) and Federally Qualified Health Centers (FQHCs) regarding additional flexibility afforded during the Coronavirus (COVID-19) pandemic national emergency.

    Of note is the expanded opportunity under the Coronavirus Aid, Relief, and Economic Security (CARES) Act for RHCs and FQHCs to serve as distant site telehealth providers for Medicare beneficiaries. RHCs and FQHCs also can provide visiting nursing services at a Medicare patient’s home with fewer requirements. Like other Medicare providers, RHCs and FQHCs are also eligible for accelerated/advanced payments from Medicare. The Accelerated and Advance Payment Program provides immediate cash payments to eligible RHCs and FQHCs of amounts up to the amount of payments received from Medicare during the last quarter of 2019. For more information on the program, see our prior article “CMS Expands Accelerated and Advance Payment Program to All Medicare Providers, Suppliers.”

    RHCs and FQHCs are an important part of the healthcare safety net, providing outpatient services in underserved areas. CMS released a fact sheet (see here and here) regarding flexibilities afforded to RHCs and FQHCs during the COVID-19 pandemic to help them continue to serve Medicare beneficiaries.

    Staffing Requirements

    CMS is temporarily waiving the requirement that a physician provide supervision of nurse practitioners (NPs) at the RHC and FQHC, but only to the extent that state law allows NPs to practice without supervision of a physician. The physician must still provide medical direction of the RHC and FQHC, as well as consultation for and supervision of other healthcare staff at the RHC and FQHC. Physicians can provide this direction, consultation and supervision via telehealth, so long as that is consistent with state supervision requirements for other healthcare staff.

    For RHCs, CMS is also waiving the requirement that an NP, physician assistant (PA) or certified nurse midwife (CNM) be available to furnish patient care services at least 50% of the time the RHC operates. CMS has not, however, waived the requirement for RHCs and FQHCs to have practitioners (e.g., physician, NP, PA, CNM, or clinical social worker or psychologist) available to furnish patient care services at all times the RHC or FQHC operates.

    Telehealth Services

    Generally, healthcare services reimbursed by Medicare must be provided by the RHC and FQHC in a face-to-face encounter between the healthcare professional and the patient. Prior to the current crisis, RHCs and FQHCs could only provide telehealth services to the Medicare beneficiary as the “originating site” of the visit, and only if certain additional location criteria were met. “Originating site” is the site where the patient is located during the service. “Distant site” is where the practitioner is located during the time of the telehealth service.

    During the period of the COVID-19 national emergency declaration, RHCs and FQHCs can serve as “distant site” telehealth providers. The otherwise applicable Medicare restrictions regarding geographic qualifications also have been temporarily removed during the national emergency, so that telehealth services can be furnished regardless of the Medicare patient’s location. For more information, see our prior article “Bipartisan Bill Relaxes Federal Telehealth Requirements in the Wake of COVID-19.”

    The standard methods of Medicare payment—an all-inclusive rate for RHCs and a prospective payment system for FQHCs—will not be used for the RHC and FQHC distant site telehealth services. Instead, CMS will create a methodology to calculate a fee-for-service rate. While CMS has not yet issued specific guidance, the CARES Act provides that RHCs and FQHCs will be paid at rates similar to the national average payment rates for comparable telehealth services under the physician fee schedule.

    In addition to allowing RHCs and FQHCs to serve as distant site telehealth providers, CMS has expanded the CPT codes eligible for payment under the coverage of “E-visits” with established patients that was implemented beginning in 2019.

    This guidance does not extend to Medicaid payments, and coverage of telehealth services is within each state’s discretion. RHCs and FQHCs should review state-specific guidance to determine what is covered by Medicaid.

    Home Nursing Visits

    Previously, RHCs and FQHCs could only provide services to homebound Medicare patients when the RHC or FQHC was located in an area with a shortage of home health agencies (HHAs). CMS has removed this restriction during the national emergency declaration and temporarily declared that any area typically served by a RHC or included in an FQHC’s service plan has a shortage of HHAs. CMS has also revised the definition of “homebound” to include Medicare patients when (1) a physician has determined it is medically necessary for a patient to remain home because he/she has been diagnosed with COVID-19, or (2) a physician has determined that is it medically necessary for a patient to remain home because he/she has a condition that may make him more susceptible to contracting COVID-19. A physician’s certification in the patient’s medical record is essential; self-quarantine or social distancing alone is not sufficient to render a Medicare patient “homebound” for this purpose.

    These changes permit significant flexibility for the expansion of home nursing visits by RHCs and FQHCs. RHCs and FQHCs should determine whether patients requesting visiting nursing services are already receiving services under a home health plan of care by an HHA. The expanded opportunities for RHC/FQHC visiting nurse services do not extend to coverage if the services overlap with a home health period of care already being provided to the patient by an HHA. CMS also clarified that a home visit that is conducted only to collect a nasal swab or throat culture for COVID-19 testing purposes is not sufficient to be considered a nursing service; however, the swab or throat culture can be combined with other services provided for the purpose of the nursing visit paid by Medicare.

    Key Takeaways: For the period of the COVID-19 national emergency, CMS has afforded RHCs and FQHCs significant expansion in the type and scope of services they may provide to Medicare beneficiaries. During this time, RHCs and FQHCs can serve as distant site telehealth Medicare providers. CMS also has expanded the services eligible for coverage under the existing “E-visit” benefit for established patients of RHCs and FQHCs. RHCs and FQHCs are permitted more flexibility to provide visiting nursing services to Medicare beneficiaries, so long as the Medicare beneficiary is not also receiving services under a home health period of care from an HHA. RHCs and FQHCs should review applicable state guidance for coverage by Medicaid for both telehealth and home nursing services.

    For more information:

    The Health Resources & Services Administration also published a list of COVID-19 FAQs, which can be found here.

    Authors

    Emily Jane Cook

    Partner

    Los Angeles, Washington, DC

    Sarah Kitchell

    Partner

    Boston

    More insights

  • The CARES Act’s Changes to Section 163(j): Partnership, International, and US State Tax Implications

    The CARES Act’s Changes to Section 163(j): Partnership, International, and US State Tax Implications

    ARTICLE / CLIENT ALERT

    The CARES Act’s Changes to Section 163(j): Partnership, International, and US State Tax Implications

    April 6, 2020

    Read time: 13 min

    Key takeaways
    Overview

    The Coronavirus Aid, Relief, and Economic Security Act (the CARES Act) relaxes the section 163(j) business interest expense limitation for tax years beginning in both 2019 and 2020. Intended to help taxpayers incurring unusually large amounts of debt due to the economic storm resulting from the Coronavirus (COVID-19) pandemic and to help with cash flow, the amendments have potential implications for partnerships and with respect to international and US state tax planning.

    In depth

    The US Congress enacted The Coronavirus Aid, Relief, and Economic Security Act (the CARES Act) on March 27, 2020. This article describes the changes to the section 163(j) business interest expense limitation as a result of the CARES Act and the impact these changes may have on taxpayers generally, as well as on partnerships and international transactions. This article also discusses the state tax impacts of this change to federal tax law.

    Section 163(j)

    Section 163(j), in its current form, was enacted as part of the Tax Cuts and Jobs Act of 2017 (the TCJA). Section 163(j) imposes a limit on the deductibility of business interest expense equal to the sum of (i) business interest income, (ii) 30% of “adjusted taxable income” (ATI), and (iii) “floor plan financing interest.” For taxable years beginning before 2022, ATI essentially is equal to a taxpayer’s earnings before interest, taxes, depreciation, amortization and depletion (EBITDA). For later taxable years, depreciation, amortization and depletion will reduce ATI. Business interest expense that is limited under section 163(j) is carried forward to future years by treating it as paid or incurred in the following taxable year.

    For partnerships and their partners, the rules are more complicated. First, the section 163(j) limitation is calculated at the partnership level, and not the partner level.

    Partnerships with fully deductible business interest expense then allocate both that business interest expense and any “excess taxable income” (ETI) (i.e., partnership ATI that was not needed to offset partnership business interest expense in the section 163(j) calculation) among their partners. Allocated ETI can be used by the partners as ATI in their partner-level 163(j) calculations, while allocated business interest expense is automatically deductible.

    Partnerships with business interest expense that is limited under section 163(j) allocate both the allowed interest expense and the disallowed interest expense, known as “excess business interest expense” (EBIE), among their partners. EBIE doesn’t immediately become part of a partner-level section 163(j) calculation. Instead, partners treat EBIE as paid or incurred in future years, but only to the extent that such partners are later allocated ETI from the same partnership. If a partnership never has ETI to allocate to its partners, the partners would never be able to deduct the EBIE previously allocated to them, but the amount of such EBIE would be added back to their partnership interest basis, reducing gain (or increasing loss, as the case may be) on the eventual disposition of their entire partnership interest.

    Amendments to Section 163(j): In General

    The CARES Act amended section 163(j) to allow taxpayers to deduct more business interest expense for any taxable year that begins in either 2019 or 2020. This will help prevent the Internal Revenue Code from penalizing taxpayers that are now incurring unusually large amounts of debt to weather the current economic storm, and it will help with taxpayers’ cash flow to the extent it (i) reduces current estimated tax payment obligations or (ii) allows taxpayers to carry back net operating losses (NOLs), thanks to the CARES Act permitting NOLs generated in 2018, 2019 or 2020 to be carried back up to five years, and to make refund claims. The ability to potentially increase an NOL through a higher interest deduction in 2019 or 2020 is particularly helpful given that the NOL could be carried back to a pre-TCJA year (where the tax rate was 35%, rather than the current 21%).

    For taxpayers generally, the CARES Act increases the 30% ATI limitation to 50% of ATI for taxable years beginning in both 2019 and 2020. Taxpayers can elect to keep the limitation at 30% of ATI for a taxable year, but would need consent to revoke such an election for the taxable year, once made.

    Section 163(j) was also amended to give taxpayers the option to use ATI for the last taxable year beginning in 2019 instead of ATI for 2020 in their 2020 section 163(j) calculations. Where short taxable years beginning in 2020 are involved, this option includes provisions for prorating the ATI in the last taxable year beginning in 2019 based on the number of months in the short 2020 year. Because, for many taxpayers, 2019 ATI will be larger than 2020 ATI, this option will generally result in more interest being deductible in 2020 and thus will generally be beneficial to taxpayers.

    Amendments to Section 163(j): Special Partnership Rules

    For partnerships, the CARES Act increases the ATI limitation to 50% only for taxable years beginning in 2020. For partnership taxable years beginning in 2019, the ATI limitation remains at 30%. However, half of a partnership’s EBIE allocated to a partner for a 2019 taxable year can automatically be treated as deductible interest expense in the partner’s first taxable year beginning in 2020. The other half of the EBIE allocated to the partner is treated as it normally would be. Partners can elect out of treating half of 2019 EBIE as automatically deductible in 2020. On the other hand, partnerships, rather than their partners, are entitled to elect out of the increase in the ATI limitation for 2020.

    Whether a partner will be better off or worse off as a result of this special rule for partnerships will depend on the facts and circumstances. For example, suppose a partnership with pro rata allocations and a calendar taxable year has $100 million of ATI in each of 2019 and 2020 (or has less ATI in 2020, but elects to substitute 2019 ATI for 2020 ATI) and no business interest income or floor plan financing interest in each year.

    • Case 1 ($40 million of business interest expense each year). For 2019, $30 million of business interest expense is immediately deductible by the partners and the remaining $10 million is EBIE, $5 million of which is automatically deductible by the partners in 2020. The other $5 million is treated by the partners as paid and incurred in a future year, to the extent the partners are allocated ETI from the partnership. For 2020, all $40 million of business interest expense is immediately deductible by the partners, and the partnership has $20 million of ETI (because only $80 million of ATI was needed to support the $40 million of deductible business interest expense). Here, the ETI is large enough that all $5 million of 2019 EBIE (that wasn’t automatically deductible) is treated as paid or incurred in 2020, and the $20 million of ETI is more than sufficient for all $5 million to be deductible in 2020 (assuming the partners don’t have negative ATI in 2020 that is unrelated to their interests in the partnership).In Case 1, all $80 million of business interest expense is deductible, as it would be if partnerships were allowed to use the same amended section 163(j) rules as other taxpayers, but $10 million of 2019 interest expense is deferred to 2020.
    • Case 2 ($50 million of business interest expense each year). For 2019, $30 million of business interest expense is immediately deductible by the partners and the remaining $20 million is EBIE, $10 million of which is automatically deductible by the partners in 2020. The other $10 million is treated by the partners as paid and incurred in a future year, to the extent the partners are allocated ETI from the partnership. For 2020, all $50 million of business interest expense is immediately deductible by the partners, and the partnership has $0 of ETI (because all $100 million of ATI was needed to support the $50 million of deductible business interest expense). Therefore, $10 million of EBIE would be deferred past 2020.In Case 2, $10 million of 2019 interest expense is deferred to 2020 and $10 million of 2019 interest expense is deferred past 2020, whereas another type of taxpayer would have been able to deduct all $50 million of interest expense in each of 2019 and 2020.
    • Case 3 ($80 million of business interest expense each year). For 2019, $30 million of business interest expense is immediately deductible by the partners and the remaining $50 million is EBIE, $25 million of which is automatically deductible by the partners in 2020. The other $25 million is treated by the partners as paid and incurred in a future year, to the extent the partners are allocated ETI from the partnership. For 2020, only $50 million of business interest expense is immediately deductible by the partners, and the partnership has $30 million of EBIE (and $0 of ETI).In Case 3, the partners would have $55 million of total EBIE, which would be deferred past 2020, $30 million of deductible interest in 2019 and $75 million of deductible interest in 2020, whereas another type of taxpayer would have been able to deduct $50 million of interest expense in each of 2019 and 2020. As with the other cases, the partners still have backloaded interest deductions, but here the total amount deductible is $5 million more than it would have been for another type of taxpayer.

    As seen in the examples above, the partnership-specific rules often operate to defer some 2019 interest deductions to 2020, but that will not always be the case for partners that have different taxable years than the partnership. For example, for partners with a calendar taxable year and partnerships with a fiscal year, items from the partnership’s last taxable year beginning in 2019 are reported on the partners’ 2020 tax returns under normal partnership tax rules. For those partners, the amended section 163(j) rule allowing 50% of the partners’ shares of EBIE to be deductible in the partners’ first taxable year beginning in 2020 will result in such interest being deductible on the partners’ same 2020 returns, and such deductions will not be deferred any further.

    Partnerships, like other taxpayers, have the option to use ATI for the last taxable year beginning in 2019 instead of ATI for 2020 in their partnership-level 2020 section 163(j) calculations. This election is made by the partnership and affects all its partners. The election will affect both the amount of allowable business interest deductions in 2020 and the amount of any 2020 ETI or EBIE allocated to the partners. The partners would then have the ability to make, or decline to make, this election with respect to their ATI arising from activities outside of the partnership.

    Amendments to Section 163(j): International Tax Impact

    The ability to use the pre-CARES Act section 163(j) rules (i.e., elect out of the increase in the ATI limitation or not elect to use 2019 ATI for the 2020 year) could be very helpful in the context of the base erosion and anti-abuse tax of section 59A (the BEAT). For example, taxpayers who could become subject to the BEAT by reason of the higher interest deductions may want to apply the pre-CARES Act section 163(j) ATI limitation (and thus carry forward disallowed interest expense indefinitely), rather than permanently waive deductions to get under the applicable BEAT threshold. Taxpayer who are currently subject to the BEAT may make the same choice in order to avoid paying additional BEAT tax on the increased interest deductions.

    In addition, if the increased interest deduction results in an NOL (or an increased NOL), the interaction of the NOL rules with the new international tax provisions of the TCJA should be considered. For instance, if a calendar year taxpayer has an NOL in 2020 that is carried back to 2015, and the taxpayer did not have sufficient income to absorb the loss in 2015 through 2017 (taking into account a section 965(n) election that is deemed made for the 2017 year under the NOL carryback rules), the NOL could be carried back to 2018 (a post-TCJA year). The NOL could increase BEAT liability in post-TCJA years. In addition, in analyzing the impact of the NOL in post-TCJA years, a 21% NOL would in effect be “lost” to the extent that it offsets income that would otherwise be subject to an effective tax rate lower than 21%. For instance, the effective tax rate on income under the FDII or the GILTI regimes could be significantly lower than 21% and yet the NOL could unfortunately be “used up” in offsetting such income.

    Amendments to Section 163(j): State Tax Impact

    From a state corporate income tax perspective, the states that conform to section 163(j) should allow the increased expense allowance in the CARES Act but only if the state law has rolling conformity to the Internal Revenue Code. In static conformity states (i.e., states that conform to the Internal Revenue Code in effect on a specific date), the CARES Act amendments would not flow-through to the state unless the state updates its conformity to the Internal Revenue Code and applies such updated conformity retroactively to 2019. This presents a significant issue in static conformity states that conform to section 163(j). In such states, not only will taxpayers not get the benefit of the increased interest expense allowance unless such states update their laws for 2019 and 2020, but such nonconformity will cause even more of a compliance burden at the state level.

    The issue is best illustrated with an example. Virginia is a static conformity state that conforms to the Internal Revenue Code as in effect on December 31, 2019. Virginia conforms to section 163(j) but also allows a state deduction equal to 20% of the amount disallowed at the federal level under section 163(j) (see Va. Code Ann. § 58.1-402(G)). Guidance issued by the Virginia Department of Taxation provides that in administering the section 163(j) limitation, the limitation must be recomputed based on the separate entity Virginia filer or based on the group that files a combined return (which is called a “consolidated return”) in Virginia. So, assuming Virginia does not update its conformity, the taxpayer would have to re-compute the federal limitation using the 30% limitation to determine the 20% expense allowance that Virginia will allow. The taxpayer would then also have to re-compute the state limitation on a separate entity or Virginia filing group basis. Of course, the process will be complicated even further if the taxpayer elects to compute the federal section 163(j) limitation in 2020 based on 2019 ATI. Thankfully, Virginia updates its Internal Revenue Code conformity regularly, but in order to give taxpayers full relief on this issue the legislature would have to update its conformity to the Internal Revenue Code effective retroactively to 2019.

    While the section 163(j) amendments in the CARES Act do provide some relief for taxpayers at the federal and possibly the state level, they also result in more compliance difficulties at the state level. As a result of the CARES Act, multistate taxpayers may have to compute their section 163(j) limitations in several ways:

    1. The section 163(j) limitation as it applied under the Internal Revenue Code before the CARES Act amendments for states that do not conform to the Internal Revenue Code as amended by the CARES Act
    2. Re-computation of the former section 163(j) limitation based on the state taxpayer or filing group in states that do not conform to the Internal Revenue Code as amended by the CARES Act
    3. The section 163(j) limitation as amended by the CARES Act and reported for federal purposes in states that conform to the Internal Revenue Code as amended by the CARES Act
    4. Re-computation of the current section 163(j) limitation based on the state taxpayer or filing group in states that conform to the Internal Revenue Code, as amended by the CARES Act.

    On top of that, carryforwards of disallowed interest expense amounts must be tracked on a state by state basis as well.

    Authors

    Caroline H. Ngo

    Partner

    Washington, DC

    David D. Sherwood

    Counsel

    Washington, DC

    More insights

  • M&A Transactions in Medium-sized Companies: The Influence of COVID-19

    M&A Transactions in Medium-sized Companies: The Influence of COVID-19

    ARTICLE

    M&A Transactions in Medium-sized Companies: The Influence of COVID-19

    April 6, 2020

    Read time: 3 min

    Key takeaways
    Overview

    To slow down the rapid spread of the global coronavirus (COVID-19) pandemic, the administrations of many countries have taken unprecedented drastic safety measures. The impact on national as well as international economy is estimated to be huge, as the historical crashes of the stock markets suggest.

    The M&A practice has not gone unaffected by this. Many prospective buyers are refraining from share deals to keep their assets together and many banks retrieve their finance commitments/agreements to provide funds. Other transactions have been postponed to Fall 2020. Unfortunately, it is still unclear if this time frame is sufficient, and only time will tell. On a positive note, this crisis may offer interesting opportunities: After a decade of steady economic success and an extremely seller-friendly development of the M&A market, the current situation could open up new, attractive opportunities regarding the drafting and negotiating of contracts for prospective buyers.

    On the seller’s side, a disposal may also be attractive during times of crisis. Family-run, medium-sized companies look out for financially strong investors for support during these challenging times. Private equity investors may also open up new options with their buy-and-build-strategy.

    In the case that M&A transactions are carried out,  impairments in terms of time are to be expected. With regard to the actual contract negotiations, the measures that have to be taken to bridge the different expectations of the purchase price have to be considered (e.g. earn-out, seller’s notes, vendor loans, reinvestment or roll-over of the management). In this regard, the consultant’s creativity is much needed.

    In this article, Dr. Michael Cziesla, partner at McDermott and Arnd Allert, managing partner at GF Allert & Co. GmbH, describe the significant interests of buyers and sellers amidst the COVID-19 crisis, as well as their protective mechanisms and their benefits for M&A practice.

    Read the full article in German here.

    In depth
    Authors
    More insights

  • CARES Act May Create More Complexities for States

    ARTICLE

    CARES Act May Create More Complexities for States

    April 6, 2020

    Read time: 1 min

    Key takeaways
    Overview
    In depth
    Authors
    More insights

  • SUB-Pay Plans: An Alternative to Severance Programs

    ARTICLE

    SUB-Pay Plans: An Alternative to Severance Programs

    April 6, 2020

    Read time: 1 min

    Key takeaways
    Overview
    In depth
    Authors
    More insights

  • COVID 19 – Special Duties and Liabilities for Managers in Germany During the Coronas Crisis

    COVID 19 – Special Duties and Liabilities for Managers in Germany During the Coronas Crisis

    ARTICLE

    COVID 19 – Special Duties and Liabilities for Managers in Germany During the Coronas Crisis

    April 6, 2020

    Read time: 2 min

    Key takeaways
    Overview

    The ongoing Coronavirus (COVID-19) crisis increases the duties and, thus, the potential liabilities of managers. They are required to make themselves familiar with new laws and economic support packages which have been put in place in light of the COVID-19 crisis in order to restructure/protect the managed business. Managers should also carefully check whether and to what extent they can rely on the newly provided suspension of insolvency filing obligations and payment prohibitions. Even if such eases apply, managers must still comply with the general rules applicable in case of an illiquidity/over-indebtedness. In particular, without limitation, entering into new contracts and/or placing orders though the payment of the consideration is at risk could constitute a fraud. In any event, even if an insolvency filing obligation is suspended, managers should find ways to cure an illiquidity/over-indebtedness as soon as possible and compare these options also with an in-court restructuring using the special restructuring tools available in the course of insolvency proceedings.

    Read the full client alert, “Besondere Pflichten und Haftungsrisiken für Geschäftsleiter in der Corona-Krise,” in German.

    In depth
    Authors

    Dr. Uwe Goetker

    Partner

    Düsseldorf

    More insights